Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Proton Treatment Facility Under Construction to Provide Therapy and Research

By HospiMedica International staff writers
Posted on 11 Oct 2011
In addition to treating patients, a new proton therapy facility being built in the United States will serve as a research center for particle therapy.

Construction on the 9,476-square meter Scripps Proton Therapy Center building on a 28,328-square meter site in Mira Mesa area of San Diego (CA, USA), is approximately 80% complete. More...
Major components of Varian’s ProBeam system for this site are already manufactured and en route to the new facility, where installation is scheduled to begin in the middle of October 2011. The center hopes to begin treating patients in 2013.

Varian Medical Systems, Inc. (Palo Alto, CA, USA) reported that it has logged a US$88 million order to provide its ProBeam system for the Scripps Proton Therapy Center, being developed through collaboration between Scripps Health, Scripps Clinic Medical Group, and Advanced Particle Therapy (Minden, NV, USA). The equipment order for the five-room center that will be operated by Scripps Health was issued by the California Proton Treatment Center (CPTC), a special purpose entity formed by Advanced Particle Therapy, which is acting as developer for the $225 million project. Concurrent with the order booking in the fourth quarter of fiscal year 2011, Varian has also recorded revenue for this equipment under the “percentage of completion method.”

Varian has also signed a 10-year agreement valued at approximately $60 million to service its ProBeam system for the center. Service revenue will be recorded in the future over the life of the contract and has not been added to the company’s backlog.

“This is an exciting step forward for the Varian particle therapy business,” said Tim Guertin, president and CEO of Varian. “The Scripps Proton Therapy Center will be our first full installation for managing, planning, and delivering intensity-modulated proton therapy.”

Proton therapy makes it possible to treat certain types of cancer more accurately and with potentially fewer side effects than with traditional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The method can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.

Related Links:
Scripps Proton Therapy Center
Varian Medical Systems



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Xenon Light Source
CLV-S400
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.